{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:00:04Z","timestamp":1793664004925,"version":"4.5.1"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008738","name":"Jeanssons Stiftelser","doi-asserted-by":"publisher","award":["JS2018-0034"],"award-info":[{"award-number":["JS2018-0034"]}],"id":[{"id":"10.13039\/100008738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006350","name":"Stiftelsen Clas Groschinskys Minnesfond","doi-asserted-by":"publisher","award":["M19351"],"award-info":[{"award-number":["M19351"]}],"id":[{"id":"10.13039\/501100006350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Svenska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","award":["SLS-960584"],"award-info":[{"award-number":["SLS-960584"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021-01683"],"award-info":[{"award-number":["2021-01683"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Bacterial vaginosis (BV) is a condition in which the vaginal microbiome presents an overgrowth of obligate and facultative anaerobes, which disturbs the vaginal microbiome balance. BV is a common and recurring vaginal infection among women of reproductive age and is associated with adverse health outcomes and a decreased quality of life. The current recommended first-line treatment for BV is antibiotics, despite the high recurrence rate. Live biopharmaceutical products\/probiotics and vaginal microbiome transplantation (VMT) have also been tested in clinical trials for BV. In this review, we discuss the advantages and challenges of current BV treatments and interventions. Furthermore, we provide our understanding of why current clinical trials with probiotics have had mixed results, which is mainly due to not administering the correct bacteria to the correct body site. Here, we propose a great opportunity for large clinical trials with probiotic strains isolated from the vaginal tract (e.g.,\n                    <jats:italic>Lactobacillus crispatus<\/jats:italic>\n                    ) and administered directly into the vagina after pretreatment.\n                  <\/jats:p>","DOI":"10.1038\/s41522-022-00295-y","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T06:02:32Z","timestamp":1651471352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["The right bug in the right place: opportunities for bacterial vaginosis treatment"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1046-3477","authenticated-orcid":false,"given":"Shengru","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa Warchavchik","family":"Hugerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1423-3089","authenticated-orcid":false,"given":"Ina","family":"Schuppe-Koistinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7649-9571","authenticated-orcid":false,"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"295_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejogrb.2019.12.035","volume":"245","author":"MS Coudray","year":"2020","unstructured":"Coudray, M. S. & Madhivanan, P. Bacterial vaginosis\u2014a brief synopsis of the literature. Eur. J. Obstet. Gynecol. Reprod. Biol. 245, 143\u2013148 (2020).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"295_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-020-00146-8","volume":"6","author":"L Cheng","year":"2020","unstructured":"Cheng, L. et al. Vaginal microbiota and human papillomavirus infection among young Swedish women. npj Biofilms Microbiomes 6, 39 (2020).","journal-title":"npj Biofilms Microbiomes"},{"key":"295_CR3","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41591-019-0465-8","volume":"25","author":"MG Serrano","year":"2019","unstructured":"Serrano, M. G. et al. Racioethnic diversity in the dynamics of the vaginal microbiome during pregnancy. Nat. Med. 25, 1001\u20131011 (2019).","journal-title":"Nat. Med."},{"key":"295_CR4","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1073\/pnas.1002611107","volume":"108","author":"J Ravel","year":"2011","unstructured":"Ravel, J. et al. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. USA 108, 4680\u20134687 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"295_CR5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/OGX.0b013e3181e09621","volume":"65","author":"G Donders","year":"2010","unstructured":"Donders, G. Diagnosis and management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: a review. Obstet. Gynecol. Surv. 65, 462\u2013473 (2010).","journal-title":"Obstet. Gynecol. Surv."},{"key":"295_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ajog.2013.05.006","volume":"209","author":"C Kenyon","year":"2013","unstructured":"Kenyon, C., Colebunders, R. & Crucitti, T. The global epidemiology of bacterial vaginosis: a systematic review. Am. J. Obstet. Gynecol. 209, 505\u2013523 (2013).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"295_CR7","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMoa043802","volume":"353","author":"DN Fredricks","year":"2005","unstructured":"Fredricks, D. N., Fiedler, T. L. & Marrazzo, J. M. Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. 353, 1899\u20131911 (2005).","journal-title":"N. Engl. J. Med."},{"key":"295_CR8","doi-asserted-by":"publisher","first-page":"e00342","DOI":"10.1128\/JCM.00342-18","volume":"56","author":"JS Coleman","year":"2018","unstructured":"Coleman, J. S. & Gaydos, C. A. Molecular diagnosis of bacterial vaginosis: an update. J. Clin. Microbiol. 56, e00342\u201318 (2018).","journal-title":"J. Clin. Microbiol."},{"key":"295_CR9","doi-asserted-by":"publisher","first-page":"e80074","DOI":"10.1371\/journal.pone.0080074","volume":"8","author":"DE O\u2019Hanlon","year":"2013","unstructured":"O\u2019Hanlon, D. E., Moench, T. R. & Cone, R. A. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS One 8, e80074 (2013).","journal-title":"PLoS One"},{"key":"295_CR10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00203-014-1003-1","volume":"196","author":"G Stoyancheva","year":"2014","unstructured":"Stoyancheva, G., Marzotto, M., Dellaglio, F. & Torriani, S. Bacteriocin production and gene sequencing analysis from vaginal lactobacillus strains. Arch. Microbiol. 196, 645\u2013653 (2014).","journal-title":"Arch. Microbiol."},{"key":"295_CR11","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1086\/324445","volume":"184","author":"AC Vallor","year":"2001","unstructured":"Vallor, A. C., Antonio, M. A., Hawes, S. E. & Hillier, S. L. Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production. J. Infect. Dis. 184, 1431\u20131436 (2001).","journal-title":"J. Infect. Dis."},{"key":"295_CR12","doi-asserted-by":"publisher","first-page":"630","DOI":"10.7326\/M14-2693","volume":"162","author":"D Drekonja","year":"2015","unstructured":"Drekonja, D. et al. Fecal microbiota transplantation for clostridium difficile infection: a systematic review. Ann. Intern. Med. 162, 630 (2015).","journal-title":"Ann. Intern. Med."},{"key":"295_CR13","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/infdis\/jiu231","volume":"210","author":"GT Spear","year":"2014","unstructured":"Spear, G. T. et al. Human \u03b1-amylase present in lower-genital-tract mucosal fluid processes glycogen to support vaginal colonization by lactobacillus. J. Infect. Dis. 210, 1019\u20131028 (2014).","journal-title":"J. Infect. Dis."},{"key":"295_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12941-020-0347-4","volume":"19","author":"N Kalia","year":"2020","unstructured":"Kalia, N., Singh, J. & Kaur, M. Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: a critical review. Ann. Clin. Microbiol. Antimicrob. 19, 5 (2020).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"295_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0418-3","volume":"6","author":"G Tachedjian","year":"2018","unstructured":"Tachedjian, G., O\u2019Hanlon, D. E. & Ravel, J. The implausible \u2018in vivo\u2019 role of hydrogen peroxide as an antimicrobial factor produced by vaginal microbiota. Microbiome 6, 29 (2018).","journal-title":"Microbiome"},{"key":"295_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-200","volume":"11","author":"DE O\u2019Hanlon","year":"2011","unstructured":"O\u2019Hanlon, D. E., Moench, T. R. & Cone, R. A. In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect. Dis. 11, 200 (2011).","journal-title":"BMC Infect. Dis."},{"key":"295_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/sextrans-2017-053506","volume":"95","author":"L Masson","year":"2019","unstructured":"Masson, L. et al. Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study. Sex. Transm. Infect. 95, 5\u201312 (2019).","journal-title":"Sex. Transm. Infect."},{"key":"295_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43849-5","volume":"9","author":"P \u0141aniewski","year":"2019","unstructured":"\u0141aniewski, P. et al. Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis. Sci. Rep. 9, 7333 (2019).","journal-title":"Sci. Rep."},{"key":"295_CR19","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3389\/fcimb.2019.00446","volume":"9","author":"DJ Delgado-Diaz","year":"2019","unstructured":"Delgado-Diaz, D. J. et al. Distinct immune responses elicited from cervicovaginal epithelial cells by lactic acid and short chain fatty acids associated with optimal and non-optimal vaginal microbiota. Front. Cell Infect. Microbiol. 9, 446 (2019).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"295_CR20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fphys.2015.00164","volume":"6","author":"M Aldunate","year":"2015","unstructured":"Aldunate, M. et al. Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front. Physiol. 6, 164 (2015).","journal-title":"Front. Physiol."},{"key":"295_CR21","doi-asserted-by":"publisher","first-page":"e00204","DOI":"10.1128\/mBio.00204-15","volume":"6","author":"S Srinivasan","year":"2015","unstructured":"Srinivasan, S. et al. Metabolic signatures of bacterial vaginosis. mBio 6, e00204\u2013e00215 (2015).","journal-title":"mBio"},{"key":"295_CR22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1086\/499824","volume":"193","author":"SR Hedges","year":"2006","unstructured":"Hedges, S. R., Barrientes, F., Desmond, R. A. & Schwebke, J. R. Local and systemic cytokine levels in relation to changes in vaginal flora. J. Infect. Dis. 193, 556\u2013562 (2006).","journal-title":"J. Infect. Dis."},{"key":"295_CR23","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1086\/503780","volume":"193","author":"CS Bradshaw","year":"2006","unstructured":"Bradshaw, C. S. et al. High recurrence rates of bacterial vaginosis over the course of 12\u2009months after oral metronidazole therapy and factors associated with recurrence. J. Infect. Dis. 193, 1478\u20131486 (2006).","journal-title":"J. Infect. Dis."},{"key":"295_CR24","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1086\/514725","volume":"28","author":"MR Joesoef","year":"1999","unstructured":"Joesoef, M. R., Schmid, G. P. & Hillier, S. L. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin. Infect. Dis. 28, S57\u2013S65 (1999).","journal-title":"Clin. Infect. Dis."},{"key":"295_CR25","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1093\/infdis\/jiw159","volume":"214","author":"CS Bradshaw","year":"2016","unstructured":"Bradshaw, C. S. & Sobel, J. D. Current treatment of bacterial vaginosis\u2014limitations and need for innovation. J. Infect. Dis. 214, S14\u2013S20 (2016).","journal-title":"J. Infect. Dis."},{"key":"295_CR26","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1128\/JCM.43.9.4492-4497.2005","volume":"43","author":"MN Austin","year":"2005","unstructured":"Austin, M. N., Beigi, R. H., Meyn, L. A. & Hillier, S. L. Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J. Clin. Microbiol 43, 4492\u20134497 (2005).","journal-title":"J. Clin. Microbiol"},{"key":"295_CR27","first-page":"443","volume":"41","author":"DG Ferris","year":"1995","unstructured":"Ferris, D. G., Litaker, M. S., Woodward, L., Mathis, D. & Hendrich, J. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J. Fam. Pract. 41, 443\u2013450 (1995).","journal-title":"J. Fam. Pract."},{"key":"295_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.anaerobe.2017.05.005","volume":"47","author":"MAB Petrina","year":"2017","unstructured":"Petrina, M. A. B., Cosentino, L. A., Rabe, L. K. & Hillier, S. L. Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin. Anaerobe 47, 115\u2013119 (2017).","journal-title":"Anaerobe"},{"key":"295_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diagmicrobio.2015.10.006","volume":"84","author":"JA Schuyler","year":"2016","unstructured":"Schuyler, J. A. et al. Identification of intrinsically metronidazole-resistant clades of Gardnerella vaginalis. Diagn. Microbiol. Infect. Dis. 84, 1\u20133 (2016).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"295_CR30","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1089\/jwh.2018.7383","volume":"28","author":"BM Faught","year":"2019","unstructured":"Faught, B. M. & Reyes, S. Characterization and treatment of recurrent bacterial vaginosis. J. Women\u2019s Health 28, 1218\u20131226 (2019).","journal-title":"J. Women\u2019s Health"},{"key":"295_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1027-4","volume":"15","author":"B Cs","year":"2015","unstructured":"Cs, B. & Rm, B. Making inroads into improving treatment of bacterial vaginosis\u2014striving for long-term cure. BMC Infect. Dis. 15, 292 (2015).","journal-title":"BMC Infect. Dis."},{"key":"295_CR32","doi-asserted-by":"publisher","first-page":"686167","DOI":"10.3389\/fcimb.2021.686167","volume":"11","author":"RS Auriemma","year":"2021","unstructured":"Auriemma, R. S. et al. The vaginal microbiome: a long urogenital colonization throughout woman life. Front. Cell Infect. Microbiol. 11, 686167 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"295_CR33","first-page":"CD006055","volume":"8","author":"OO Oyinlola","year":"2009","unstructured":"Oyinlola, O. O., Rose, I. A. & Folasade, T. O. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst. Rev. 8, CD006055 (2009).","journal-title":"Cochrane Database Syst. Rev."},{"key":"295_CR34","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1586\/eri.09.87","volume":"7","author":"V Hans","year":"2009","unstructured":"Hans, V. & Rita, V. Bacterial vaginosis: an update on diagnosis and treatment. Expert Rev. Anti Infect. Ther. 7, 1109\u20131124 (2009).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"295_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-4-5","volume":"4","author":"MJ Ferris","year":"2004","unstructured":"Ferris, M. J. et al. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect. Dis. 4, 5 (2004).","journal-title":"BMC Infect. Dis."},{"key":"295_CR36","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jinf.2019.10.008","volume":"79","author":"P Zimmermann","year":"2019","unstructured":"Zimmermann, P. & Curtis, N. The effect of antibiotics on the composition of the intestinal microbiota\u2014a systematic review. J. Infect. 79, 471\u2013489 (2019).","journal-title":"J. Infect."},{"key":"295_CR37","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1111\/jvim.15871","volume":"34","author":"R Pilla","year":"2020","unstructured":"Pilla, R. et al. Effects of metronidazole on the fecal microbiome and metabolome in healthy dogs. J. Vet. Intern. Med. 34, 1853\u20131866 (2020).","journal-title":"J. Vet. Intern. Med."},{"key":"295_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-019-0700-y","volume":"21","author":"A Shukla","year":"2019","unstructured":"Shukla, A. & Sobel, J. D. Vulvovaginitis caused by candida species following antibiotic exposure. Curr. Infect. Dis. Rep. 21, 44 (2019).","journal-title":"Curr. Infect. Dis. Rep."},{"key":"295_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.18502\/cmm.4.1.27","volume":"4","author":"L Jacob","year":"2018","unstructured":"Jacob, L., John, M., Kalder, M. & Kostev, K. Prevalence of vulvovaginal candidiasis in gynecological practices in Germany: a retrospective study of 954,186 patients. Curr. Med. Mycol. 4, 6\u201311 (2018).","journal-title":"Curr. Med. Mycol."},{"key":"295_CR40","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1086\/598686","volume":"199","author":"MAD Antonio","year":"2009","unstructured":"Antonio, M. A. D., Meyn, L. A., Murray, P. J., Busse, B. & Hillier, S. L. Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli. J. Infect. Dis. 199, 1506\u20131513 (2009).","journal-title":"J. Infect. Dis."},{"key":"295_CR41","doi-asserted-by":"publisher","first-page":"e102467","DOI":"10.1371\/journal.pone.0102467","volume":"9","author":"P Mirmonsef","year":"2014","unstructured":"Mirmonsef, P. et al. Free glycogen in vaginal fluids is associated with Lactobacillus colonization and low vaginal pH. PLoS One 9, e102467 (2014).","journal-title":"PLoS One"},{"key":"295_CR42","doi-asserted-by":"publisher","first-page":"IDRT.S3903","DOI":"10.4137\/IDRT.S3903","volume":"3","author":"MA Farage","year":"2010","unstructured":"Farage, M. A., Miller, K. W. & Sobel, J. D. Dynamics of the vaginal ecosystem\u2014hormonal influences. Infect. Dis. (Auckl.) 3, IDRT.S3903 (2010).","journal-title":"Infect. Dis. (Auckl.)"},{"key":"295_CR43","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/genes11040360","volume":"11","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. Comparative genomics of Lactobacillus crispatus from the gut and vagina reveals genetic diversity and lifestyle adaptation. Genes 11, 360 (2020).","journal-title":"Genes"},{"key":"295_CR44","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1093\/femsre\/fux030","volume":"41","author":"RM Duar","year":"2017","unstructured":"Duar, R. M. et al. Lifestyles in transition: evolution and natural history of the genus Lactobacillus. FEMS Microbiol. Rev. 41, S27\u2013S48 (2017).","journal-title":"FEMS Microbiol. Rev."},{"key":"295_CR45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/MPG.0000000000001603","volume":"65","author":"S Kola\u010dek","year":"2017","unstructured":"Kola\u010dek, S. et al. Commercial probiotic products: a call for improved quality control. A position paper by the ESPGHAN working group for probiotics and prebiotics. J. Pediatr. Gastroenterol. Nutr. 65, 117\u2013124 (2017).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"295_CR46","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-2180-9-116","volume":"9","author":"H Verstraelen","year":"2009","unstructured":"Verstraelen, H. et al. Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal microflora and that L. gasseri and\/or L. iners are more conducive to the occurrence of abnormal vaginal microflora. BMC Microbiol. 9, 116 (2009).","journal-title":"BMC Microbiol."},{"key":"295_CR47","doi-asserted-by":"crossref","unstructured":"Pan, M., Hidalgo-Cantabrana, C., Goh, Y. J., Sanozky-Dawes, R. & Barrangou, R. Comparative analysis of Lactobacillus gasseri and Lactobacillus crispatus isolated from human urogenital and gastrointestinal tracts. Front. Microbiol. 10, 3146 (2020).","DOI":"10.3389\/fmicb.2019.03146"},{"key":"295_CR48","doi-asserted-by":"crossref","unstructured":"Mancabelli, L. et al. Comparative genome analyses of Lactobacillus crispatus isolates from different ecological niches reveal an adaptation of this species to the human vaginal environment. Appl. Environ. Microbiol. 87, e02899\u201320 (2021).","DOI":"10.1128\/AEM.02899-20"},{"key":"295_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-38253-4","volume":"9","author":"E Chetwin","year":"2019","unstructured":"Chetwin, E. et al. Antimicrobial and inflammatory properties of South African clinical Lactobacillus isolates and vaginal probiotics. Sci. Rep. 9, 1917 (2019).","journal-title":"Sci. Rep."},{"key":"295_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-019-0667-9","volume":"7","author":"C van der Veer","year":"2019","unstructured":"van der Veer, C. et al. Comparative genomics of human Lactobacillus crispatus isolates reveals genes for glycosylation and glycogen degradation: implications for in vivo dominance of the vaginal microbiota. Microbiome 7, 49 (2019).","journal-title":"Microbiome"},{"key":"295_CR51","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jogoh.2017.11.005","volume":"47","author":"JM Bohbot","year":"2018","unstructured":"Bohbot, J. M. et al. Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence. J. Gynecol. Obstet. Hum. Reprod. 47, 81\u201386 (2018).","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"295_CR52","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1097\/OLQ.0b013e3182267ac4","volume":"38","author":"BM Ngugi","year":"2011","unstructured":"Ngugi, B. M. et al. Effects of BV-associated bacteria and sexual Intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05. Sex. Transm. Dis. 38, 1020\u20131027 (2011).","journal-title":"Sex. Transm. Dis."},{"key":"295_CR53","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1056\/NEJMoa1915254","volume":"382","author":"CR Cohen","year":"2020","unstructured":"Cohen, C. R. et al. Randomized trial of lactin-V to prevent recurrence of bacterial vaginosis. N. Engl. J. Med. 382, 1906\u20131915 (2020).","journal-title":"N. Engl. J. Med."},{"key":"295_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3920\/BM2017.0018","volume":"9","author":"C Laue","year":"2018","unstructured":"Laue, C. et al. Effect of a yoghurt drink containing Lactobacillus strains on bacterial vaginosis in women\u2014a double-blind, randomised, controlled clinical pilot trial. Benef. Microbes 9, 35\u201350 (2018).","journal-title":"Benef. Microbes"},{"key":"295_CR55","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejogrb.2012.12.031","volume":"168","author":"G Vujic","year":"2013","unstructured":"Vujic, G., Jajac Knez, A., Despot Stefanovic, V. & Kuzmic Vrbanovic, V. Efficacy of orally applied probiotic capsules for bacterial vaginosis and other vaginal infections: a double-blind, randomized, placebo-controlled study. Eur. J. Obstet. Gynecol. Reprod. Biol. 168, 75\u201379 (2013).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"295_CR56","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1016\/j.micinf.2006.08.008","volume":"8","author":"KC Anukam","year":"2006","unstructured":"Anukam, K. C. et al. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect. 8, 2772\u20132776 (2006).","journal-title":"Microbes Infect."},{"key":"295_CR57","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.micinf.2006.01.003","volume":"8","author":"K Anukam","year":"2006","unstructured":"Anukam, K. et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect. 8, 1450\u20131454 (2006).","journal-title":"Microbes Infect."},{"key":"295_CR58","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1139\/W08-102","volume":"55","author":"RCR Martinez","year":"2009","unstructured":"Martinez, R. C. R. et al. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Can. J. Microbiol. 55, 133\u2013138 (2009).","journal-title":"Can. J. Microbiol."},{"key":"295_CR59","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ijgo.2010.07.008","volume":"111","author":"R Hummelen","year":"2010","unstructured":"Hummelen, R. et al. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV. Int J. Gynaecol. Obstet. 111, 245\u2013248 (2010).","journal-title":"Int J. Gynaecol. Obstet."},{"key":"295_CR60","doi-asserted-by":"publisher","first-page":"e104511","DOI":"10.1371\/journal.pone.0104511","volume":"9","author":"JE Bisanz","year":"2014","unstructured":"Bisanz, J. E. et al. A systems biology approach investigating the effect of probiotics on the vaginal microbiome and host responses in a double blind, placebo-controlled clinical trial of post-menopausal women. PLoS One 9, e104511 (2014).","journal-title":"PLoS One"},{"key":"295_CR61","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijantimicag.2006.05.008","volume":"28","author":"S Uehara","year":"2006","unstructured":"Uehara, S. et al. A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection. Int J. Antimicrob. Agents 28, 30\u201334 (2006).","journal-title":"Int J. Antimicrob. Agents"},{"key":"295_CR62","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/cid\/cir183","volume":"52","author":"AE Stapleton","year":"2011","unstructured":"Stapleton, A. E. et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin. Infect. Dis. 52, 1212\u20131217 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"295_CR63","doi-asserted-by":"publisher","first-page":"e35387","DOI":"10.1155\/2007\/35387","volume":"2007","author":"CA Czaja","year":"2007","unstructured":"Czaja, C. A., Stapleton, A. E., Yarova-Yarovaya, Y. & Stamm, W. E. Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infect. Dis. Obstet. Gynecol. 2007, e35387 (2007).","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"295_CR64","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0928-8244(02)00465-0","volume":"35","author":"G Reid","year":"2003","unstructured":"Reid, G. et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol. Med. Microbiol. 35, 131\u2013134 (2003).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"295_CR65","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12905-015-0246-6","volume":"15","author":"PB Heczko","year":"2015","unstructured":"Heczko, P. B. et al. Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial. BMC Women\u2019s Health 15, 115 (2015).","journal-title":"BMC Women\u2019s Health"},{"key":"295_CR66","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3920\/BM2018.0075","volume":"10","author":"R Russo","year":"2019","unstructured":"Russo, R. & Karadja, E. & De Seta, F. Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial. Benef. Microbes 10, 19\u201326 (2019).","journal-title":"Benef. Microbes"},{"key":"295_CR67","first-page":"171","volume":"28","author":"\u015e \u00d6zmen","year":"1998","unstructured":"\u00d6zmen, \u015e., Turhan, N. \u00d6. & Se\u00e7ki\u0307n, N. C. Garnerella-associated vaginitis: comparison of three treatment modalities. Turk. J. Med. Sci. 28, 171\u2013174 (1998).","journal-title":"Turk. J. Med. Sci."},{"key":"295_CR68","doi-asserted-by":"publisher","first-page":"fnz025","DOI":"10.1093\/femsle\/fnz025","volume":"366","author":"D Ma","year":"2019","unstructured":"Ma, D., Chen, Y. & Chen, T. Vaginal microbiota transplantation for the treatment of bacterial vaginosis: a conceptual analysis. FEMS Microbiol Lett. 366, fnz025 (2019).","journal-title":"FEMS Microbiol Lett."},{"key":"295_CR69","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1177\/1073110519897731","volume":"47","author":"K DeLong","year":"2019","unstructured":"DeLong, K., Zulfiqar, F., Hoffmann, D. E., Tarzian, A. J. & Ensign, L. M. Vaginal microbiota transplantation: the next frontier. J. Law Med. Ethics 47, 555\u2013567 (2019).","journal-title":"J. Law Med. Ethics"},{"key":"295_CR70","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/s41591-019-0600-6","volume":"25","author":"A Lev-Sagie","year":"2019","unstructured":"Lev-Sagie, A. et al. Vaginal microbiome transplantation in women with intractable bacterial vaginosis. Nat. Med. 25, 1500\u20131504 (2019).","journal-title":"Nat. Med."},{"key":"295_CR71","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/cid\/ciu1130","volume":"60","author":"LA Vodstrcil","year":"2015","unstructured":"Vodstrcil, L. A. et al. Incident bacterial vaginosis (BV) in women who have sex with women is associated with behaviors that suggest sexual transmission of BV. Clin. Infect. Dis. 60, 1042\u20131053 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"295_CR72","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1056\/NEJMe1913807","volume":"381","author":"MJ Blaser","year":"2019","unstructured":"Blaser, M. J. Fecal microbiota transplantation for dysbiosis\u2014predictable risks. N. Engl. J. Med. 381, 2064\u20132066 (2019).","journal-title":"N. Engl. J. Med."},{"key":"295_CR73","unstructured":"United States Food and Drug Administration. Fecal microbiota for transplantation: safety alert\u2014risk of serious adverse events likely due to transmission of pathogenic organisms. FDA. https:\/\/www.fda.gov\/safety\/medical-product-safety-information\/fecal-microbiota-transplantation-safety-alert-risk-serious-adverse-events-likely-due-transmission (2020)."},{"key":"295_CR74","unstructured":"United States Food and Drug Administration. Bacterial vaginosis: developing drugs for treatment; draft guidance for industry; availability. FDA. https:\/\/www.regulations.gov\/docket\/FDA-2016-D-1659\/document (2016)."},{"key":"295_CR75","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1136\/gutjnl-2019-319548","volume":"68","author":"G Cammarota","year":"2019","unstructured":"Cammarota, G. et al. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut 68, 2111\u20132121 (2019).","journal-title":"Gut"},{"key":"295_CR76","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5946\/ce.2019.009","volume":"52","author":"KO Kim","year":"2019","unstructured":"Kim, K. O. & Gluck, M. Fecal microbiota transplantation: an update on clinical practice. Clin. Endosc. 52, 137\u2013143 (2019).","journal-title":"Clin. Endosc."},{"key":"295_CR77","doi-asserted-by":"crossref","unstructured":"Gordillo Altamirano, F. L. & Barr, J. J. Phage therapy in the postantibiotic Era. Clin Microbiol Rev.s 32, e00066\u201318 (2019).","DOI":"10.1128\/CMR.00066-18"},{"key":"295_CR78","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1099\/jmm.0.024463-0","volume":"60","author":"LH Damelin","year":"2011","unstructured":"Damelin, L. H. et al. Identification of predominant culturable vaginal Lactobacillus species and associated bacteriophages from women with and without vaginal discharge syndrome in South Africa. J. Med Microbiol 60, 180\u2013183 (2011).","journal-title":"J. Med Microbiol"},{"key":"295_CR79","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3390\/v12101143","volume":"12","author":"RR Jakobsen","year":"2020","unstructured":"Jakobsen, R. R. et al. Characterization of the vaginal DNA virome in health and dysbiosis. Viruses 12, 1143 (2020).","journal-title":"Viruses"},{"key":"295_CR80","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41564-018-0338-9","volume":"4","author":"AE Devoto","year":"2019","unstructured":"Devoto, A. E. et al. Megaphages infect Prevotella and variants are widespread in gut microbiomes. Nat. Microbiol 4, 693\u2013700 (2019).","journal-title":"Nat. Microbiol"},{"key":"295_CR81","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/cid\/civ353","volume":"61","author":"CA Muzny","year":"2015","unstructured":"Muzny, C. A. & Schwebke, J. R. Biofilms: an underappreciated mechanism of treatment failure and recurrence in vaginal infections. Clin. Infect. Dis. 61, 601\u2013606 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"295_CR82","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.tim.2014.02.001","volume":"22","author":"H Van Acker","year":"2014","unstructured":"Van Acker, H., Van Dijck, P. & Coenye, T. Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms. Trends Microbiol 22, 326\u2013333 (2014).","journal-title":"Trends Microbiol"},{"key":"295_CR83","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/infdis\/jiz342","volume":"220","author":"CA Muzny","year":"2019","unstructured":"Muzny, C. A. et al. An updated conceptual model on the pathogenesis of bacterial vaginosis. J. Infect. Dis. 220, 1399\u20131405 (2019).","journal-title":"J. Infect. Dis."},{"key":"295_CR84","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/QCO.0000000000000620","volume":"33","author":"CA Muzny","year":"2020","unstructured":"Muzny, C. A., \u0141aniewski, P., Schwebke, J. R. & Herbst-Kralovetz, M. M. Host-vaginal microbiota interactions in the pathogenesis of bacterial vaginosis. Curr. Opin. Infect. Dis. 33, 59\u201365 (2020).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"295_CR85","first-page":"219","volume":"3","author":"SE Dover","year":"2008","unstructured":"Dover, S. E., Aroutcheva, A. A., Faro, S. & Chikindas, M. L. Natural antimicrobials and their role in vaginal health: a short review. Int J. Probiotics Prebiotics 3, 219\u2013230 (2008).","journal-title":"Int J. Probiotics Prebiotics"},{"key":"295_CR86","doi-asserted-by":"publisher","first-page":"566325","DOI":"10.3389\/fmicb.2020.566325","volume":"11","author":"R Mishra","year":"2020","unstructured":"Mishra, R. et al. Natural anti-biofilm agents: strategies to control biofilm-forming pathogens. Front. Microbiol. 11, 566325 (2020).","journal-title":"Front. Microbiol."},{"key":"295_CR87","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/cid\/ciy554","volume":"68","author":"JM Marrazzo","year":"2019","unstructured":"Marrazzo, J. M. et al. Safety and efficacy of a novel vaginal anti-infective, TOL-463, in the treatment of bacterial vaginosis and vulvovaginal candidiasis: a randomized, Single-blind, Phase 2, controlled trial. Clin. Infect. Dis. 68, 803\u2013809 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"295_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0326-y","volume":"5","author":"C Gottschick","year":"2017","unstructured":"Gottschick, C. et al. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis. Microbiome 5, 119 (2017).","journal-title":"Microbiome"},{"key":"295_CR89","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ejogrb.2020.11.059","volume":"256","author":"HC Latham-Cork","year":"2021","unstructured":"Latham-Cork, H. C. et al. A novel non-antimicrobial treatment of bacterial vaginosis: An open label two-private centre study. Eur. J. Obstet. Gynecol. Reprod. Biol. 256, 419\u2013424 (2021).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"295_CR90","unstructured":"Sexual Health and Wellness Institute. Clinical Trial to Survey Results of Flourish Vaginal Care System for Recurrent Bacterial Vaginosis. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03734523 (2021)."},{"key":"295_CR91","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3390\/molecules26051249","volume":"26","author":"S Puebla-Barragan","year":"2021","unstructured":"Puebla-Barragan, S. & Reid, G. Probiotics in cosmetic and personal care products: trends and challenges. Molecules 26, 1249 (2021).","journal-title":"Molecules"},{"key":"295_CR92","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s13238-018-0537-4","volume":"9","author":"Y Ma","year":"2018","unstructured":"Ma, Y., Chen, H., Lan, C. & Ren, J. Help, hope and hype: ethical considerations of human microbiome research and applications. Protein Cell 9, 404\u2013415 (2018).","journal-title":"Protein Cell"},{"key":"295_CR93","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12905-019-0723-4","volume":"19","author":"L Buggio","year":"2019","unstructured":"Buggio, L., Somigliana, E., Borghi, A. & Vercellini, P. Probiotics and vaginal microecology: fact or fancy? BMC Women\u2019s Health 19, 25 (2019).","journal-title":"BMC Women\u2019s Health"},{"key":"295_CR94","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/19490976.2017.1293223","volume":"8","author":"DE Hoffmann","year":"2017","unstructured":"Hoffmann, D. E., Palumbo, F. B., Ravel, J., Rowthorn, V. & von Rosenvinge, E. A proposed definition of microbiota transplantation for regulatory purposes. Gut Microbes 8, 208\u2013213 (2017).","journal-title":"Gut Microbes"},{"key":"295_CR95","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1093\/infdis\/jiw130","volume":"214","author":"MM Herbst-Kralovetz","year":"2016","unstructured":"Herbst-Kralovetz, M. M., Pyles, R. B., Ratner, A. J., Sycuro, L. K. & Mitchell, C. New systems for studying intercellular interactions in bacterial vaginosis. J. Infect. Dis. 214, S6\u2013S13 (2016).","journal-title":"J. Infect. Dis."},{"key":"295_CR96","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/s41396-018-0337-0","volume":"13","author":"J Castro","year":"2019","unstructured":"Castro, J., Machado, D. & Cerca, N. Unveiling the role of Gardnerella vaginalis in polymicrobial bacterial vaginosis biofilms: the impact of other vaginal pathogens living as neighbors. ISME J. 13, 1306\u20131317 (2019).","journal-title":"ISME J."},{"key":"295_CR97","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3109\/14767058.2011.614654","volume":"25","author":"S Hantoushzadeh","year":"2012","unstructured":"Hantoushzadeh, S. et al. Comparative efficacy of probiotic yoghurt and clindamycin in treatment of bacterial vaginosis in pregnant women: a randomized clinical trial. J. Matern Fetal. Neonatal. Med. 25, 1021\u20131024 (2012).","journal-title":"J. Matern Fetal. Neonatal. Med."},{"key":"295_CR98","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/00007435-199205000-00007","volume":"19","author":"A Hall\u00e9n","year":"1992","unstructured":"Hall\u00e9n, A., Jarstrand, C. & P\u00e5hlson, C. Treatment of bacterial vaginosis with lactobacilli. Sex. Transm. Dis. 19, 146\u2013148 (1992).","journal-title":"Sex. Transm. Dis."},{"key":"295_CR99","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/00016349309013342","volume":"72","author":"A Neri","year":"1993","unstructured":"Neri, A., Sabah, G. & Samra, Z. Bacterial vaginosis in pregnancy treated with yoghurt. Acta Obstet. Gynecol. Scand. 72, 17\u201319 (1993).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"295_CR100","first-page":"68","volume":"46","author":"D Parent","year":"1996","unstructured":"Parent, D. et al. Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol: a placebo-controlled multicentric clinical trial. Arzneimittelforschung 46, 68\u201373 (1996).","journal-title":"Arzneimittelforschung"},{"key":"295_CR101","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1469-0691.2008.02112.x","volume":"15","author":"P Mastromarino","year":"2009","unstructured":"Mastromarino, P. et al. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clin. Microbiol Infect. 15, 67\u201374 (2009).","journal-title":"Clin. Microbiol Infect."},{"key":"295_CR102","doi-asserted-by":"publisher","first-page":"120.e1","DOI":"10.1016\/j.ajog.2010.05.023","volume":"203","author":"W Ya","year":"2010","unstructured":"Ya, W., Reifer, C. & Miller, L. E. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study. Am. J. Obstet. Gynecol. 203, 120.e1\u20136 (2010).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"295_CR103","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00248-012-0154-3","volume":"65","author":"Z Ling","year":"2013","unstructured":"Ling, Z. et al. The restoration of the vaginal microbiota after treatment for bacterial vaginosis with metronidazole or probiotics. Micro. Ecol. 65, 773\u2013780 (2013).","journal-title":"Micro. Ecol."},{"key":"295_CR104","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1097\/MCG.0000000000000226","volume":"48","author":"F Vicariotto","year":"2014","unstructured":"Vicariotto, F., Mogna, L. & Del Piano, M. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study. J. Clin. Gastroenterol. 48, S106 (2014).","journal-title":"J. Clin. Gastroenterol."},{"key":"295_CR105","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.micinf.2010.04.010","volume":"12","author":"S Ehrstr\u00f6m","year":"2010","unstructured":"Ehrstr\u00f6m, S. et al. Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis. Microbes Infect. 12, 691\u2013699 (2010).","journal-title":"Microbes Infect."},{"key":"295_CR106","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/00015550410022249","volume":"85","author":"K Eriksson","year":"2005","unstructured":"Eriksson, K., Carlsson, B., Forsum, U. & Larsson, P.-G. A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules. Acta Derm. Venereol. 85, 42\u201346 (2005).","journal-title":"Acta Derm. Venereol."},{"key":"295_CR107","first-page":"429","volume":"31","author":"V Marcone","year":"2008","unstructured":"Marcone, V., Calzolari, E. & Bertini, M. Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: how to lower the rate of bacterial vaginosis recurrences. N. Microbiol 31, 429\u2013433 (2008).","journal-title":"N. Microbiol"},{"key":"295_CR108","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/j.1471-0528.2008.01882.x","volume":"115","author":"L Petricevic","year":"2008","unstructured":"Petricevic, L. & Witt, A. The role of Lactobacillus casei rhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis. BJOG 115, 1369\u20131374 (2008).","journal-title":"BJOG"},{"key":"295_CR109","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1472-6874-8-3","volume":"8","author":"P-G Larsson","year":"2008","unstructured":"Larsson, P.-G., Stray-Pedersen, B., Ryttig, K. R. & Larsen, S. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Women\u2019s Health 8, 3 (2008).","journal-title":"BMC Women\u2019s Health"},{"key":"295_CR110","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ijgo.2010.04.025","volume":"110","author":"V Marcone","year":"2010","unstructured":"Marcone, V., Rocca, G., Lichtner, M. & Calzolari, E. Long-term vaginal administration of Lactobacillus rhamnosus as a complementary approach to management of bacterial vaginosis. Int J. Gynaecol. Obstet. 110, 223\u2013226 (2010).","journal-title":"Int J. Gynaecol. Obstet."},{"key":"295_CR111","doi-asserted-by":"publisher","first-page":"e34540","DOI":"10.1371\/journal.pone.0034540","volume":"7","author":"CS Bradshaw","year":"2012","unstructured":"Bradshaw, C. S. et al. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial. PLoS One 7, e34540 (2012).","journal-title":"PLoS One"},{"key":"295_CR112","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00404-015-3810-2","volume":"293","author":"N Recine","year":"2016","unstructured":"Recine, N. et al. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case\u2013control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis. Arch. Gynecol. Obstet. 293, 101\u2013107 (2016).","journal-title":"Arch. Gynecol. Obstet."}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-022-00295-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-022-00295-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-022-00295-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T13:45:50Z","timestamp":1669297550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-022-00295-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["295"],"URL":"https:\/\/doi.org\/10.1038\/s41522-022-00295-y","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"assertion":[{"value":"25 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}